2 Results for "

1225037-39-7

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "1225037-39-7" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-12868
CAS No.: 1225037-39-7
Purity:  98.62%
Synonyms: PQR309
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

Bimiralisib (PQR309) is an orally active, blood-brain barrier-penetrant PI3K/mTOR inhibitor with in vitro antiproliferative activity and in vivo antitumor activity. Bimiralisib induces G1 cell cycle arrest, apoptosis and cell death in cancer cells, while inhibiting cancer cell proliferation, migration, invasion, colony formation and spheroid generation. Bimiralisib upregulates the expression of E2F4. The combination of Bimiralisib with venetoclax enhances therapeutic efficacy in acute myeloid leukemia models. Bimiralisib can be used in cancer-related research .
loading...
    loading...
Cat. No.: HY-12868A
CAS No.: 1820902-72-4
Synonyms: PQR309 hydrochloride
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

Bimiralisib hydrochloride (PQR309 hydrochloride) is an orally active, blood-brain barrier-penetrant PI3K/mTOR inhibitor with in vitro antiproliferative activity and in vivo antitumor activity. Bimiralisib hydrochloride induces G1 cell cycle arrest, apoptosis and cell death in cancer cells, while inhibiting cancer cell proliferation, migration, invasion, colony formation and spheroid generation. Bimiralisib hydrochloride upregulates the expression of E2F4. The combination of Bimiralisib hydrochloride with venetoclax enhances therapeutic efficacy in acute myeloid leukemia models. Bimiralisib hydrochloride can be used in cancer-related research .
loading...
    loading...